Tomoyuki Tahara
- Hematology top 1%
- Genetics top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Takashi KatoAtsushi MatsumotoHiroshi MiyazakiHaruhiko MoritaShigetaka ShimodairaNaoaki IchikawaFumihiro IshidaKiyoshi Kitano
- Topics
- Platelet Disorders and Treatments (27 papers)Lipid metabolism and disorders (16 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)
- Cited by
- HematologyGeneticsVirology
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Tomoyuki Tahara
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 80
- Hematology 807
- Genetics 276
- Molecular Biology 248
- Pulmonary and Respiratory Medicine 225
- Cardiology and Cardiovascular Medicine 196
Countries citing papers authored by Tomoyuki Tahara
This map shows the geographic impact of Tomoyuki Tahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Tahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Tahara more than expected).
Fields of papers citing papers by Tomoyuki Tahara
This network shows the impact of papers produced by Tomoyuki Tahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Tahara. The network helps show where Tomoyuki Tahara may publish in the future.
Co-authorship network of co-authors of Tomoyuki Tahara
This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Tahara. A scholar is included among the top collaborators of Tomoyuki Tahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Tahara. Tomoyuki Tahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 3 | |
| 3 | 45 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 97 | |
| 7 | 17 | |
| 8 | 26 | |
| 9 | 6 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 37 | |
| 13 | 1 | |
| 14 | 19 | |
| 15 | 27 | |
| 16 | 13 | |
| 17 | 172 | |
| 18 | 31 | |
| 19 | Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. | 52 |
| 20 | 2 |
About Tomoyuki Tahara
Tomoyuki Tahara is a scholar working on Hematology, Genetics and Nephrology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (27 papers), Lipid metabolism and disorders (16 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Hematology (807 citations), Genetics (276 citations) and Virology (86 citations). Tomoyuki Tahara has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takashi Kato, Atsushi Matsumoto, Hiroshi Miyazaki, Haruhiko Morita, Shigetaka Shimodaira, Naoaki Ichikawa, Fumihiro Ishida, Kiyoshi Kitano, Kensuke Usuki and Akio Urabe. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.